MannKind Corporation (MNKD): Price and Financial Metrics
MNKD Price/Volume Stats
| Current price | $4.18 | 52-week high | $5.75 |
| Prev. close | $4.08 | 52-week low | $3.17 |
| Day low | $4.02 | Volume | 1,795,644 |
| Day high | $4.20 | Avg. volume | 3,008,478 |
| 50-day MA | $4.26 | Dividend yield | N/A |
| 200-day MA | $4.10 | Market Cap | 1.13B |
MNKD Stock Price Chart Interactive Chart >
MannKind Corporation (MNKD) Company Bio
MannKind Corporation focuses on the discovery, development, and commercialization of therapeutic products for diabetes in the United States. The company was founded in 1991 and is based in Valencia, California.
Latest MNKD News From Around the Web
Below are the latest news stories about MANNKIND CORP that investors may wish to consider to help them evaluate MNKD as an investment opportunity.
MannKind Corporation to Present at 42nd Annual J.P. Morgan Healthcare ConferenceDANBURY, Conn. and WESTLAKE VILLAGE, Calif., Dec. 28, 2023 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases, announced today that its Chief Executive Officer, Michael Castagna, PharmD, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024 at 11:15 AM PST at the Westin St. Francis Hotel in San Francisco, Ca |
Insider Sell: CEO Michael Castagna Offloads 200,482 Shares of MannKind Corp (MNKD)In a significant move within the pharmaceutical industry, CEO Michael Castagna has parted with a substantial number of shares in MannKind Corp (NASDAQ:MNKD). |
High-Yield Haven: 3 Dividend Stocks to Secure NowThese are three different dividend stocks that have a great dividend yield and offer a reliable source of income. |
Investors in MannKind (NASDAQ:MNKD) have seen solid returns of 115% over the past five yearsIt hasn't been the best quarter for MannKind Corporation ( NASDAQ:MNKD ) shareholders, since the share price has fallen... |
MannKind Corporation (NASDAQ:MNKD) Q3 2023 Earnings Call TranscriptMannKind Corporation (NASDAQ:MNKD) Q3 2023 Earnings Call Transcript November 7, 2023 MannKind Corporation beats earnings expectations. Reported EPS is $0.01, expectations were $-0.02. Operator: Good afternoon and welcome to the MannKind Corporation 2023 Third Quarter Financial Results Earnings Call. As a reminder, this call is being recorded on November 7th, 2023, and will be available […] |
MNKD Price Returns
| 1-mo | -13.28% |
| 3-mo | 24.40% |
| 6-mo | -0.71% |
| 1-year | 3.72% |
| 3-year | -1.18% |
| 5-year | 173.20% |
| YTD | 14.84% |
| 2023 | -30.93% |
| 2022 | 20.59% |
| 2021 | 39.62% |
| 2020 | 142.64% |
| 2019 | 21.70% |
Continue Researching MNKD
Want to do more research on Mannkind Corp's stock and its price? Try the links below:Mannkind Corp (MNKD) Stock Price | Nasdaq
Mannkind Corp (MNKD) Stock Quote, History and News - Yahoo Finance
Mannkind Corp (MNKD) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...